Literature DB >> 21147953

Candida palmioleophila: characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species.

Rasmus H Jensen1, Maiken C Arendrup.   

Abstract

Candida palmioleophila has previously been misidentified as C. famata or C. guilliermondii. We have investigated traditional and modern identification methods for the identification of this and related species. Forty-one clinical isolates previously identified as C. famata or C. guilliermondii and 8 reference strains were included. Color development on CHROMagar, growth temperature ranges, micromorphologies, carbon assimilation (ID32C), matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) profiles, and susceptibility profiles (mica- and anidulafungin and itra-, vori-, posa-, and fluconazole MICs were determined by EUCAST method EDef 7.1, and caspofungin MICs were determined by Etest) were determined, and results were compared to those of molecular identification (ITS1 and ITS2 sequencing). The following five different species were identified among the clinical isolates by sequencing, but no C. famata isolates were found: C. guilliermondii (22 isolates), C. palmioleophila (8 isolates), C. fermentati (6 isolates), C. lusitaniae (3 isolates), and C. intermedia (2 isolates). C. palmioleophila developed a distinct scintillating color of turquoise to rose, grew at 40°C, and failed to produce pseudohyphae within 14 days. The ID32C profile for 7/9 C. palmioleophila isolates was 5367352315, and all were unable to hydrolyze esculin (Esc). The six related species were well discriminated by MALDI-TOF MS. The susceptibility pattern for C. palmioleophila was unique, as the echinocandin MICs were low (range, 0.008 to 0.125 μg/ml) and fluconazole MICs were high (range, 8 to >16 μg/ml). Correct identification of C. palmioleophila is important due to its unique susceptibility profile. Identification is possible yet laborious with conventional techniques, whereas MALDI-TOF MS easily separated the related species.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21147953      PMCID: PMC3043495          DOI: 10.1128/JCM.02071-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  46 in total

1.  Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility.

Authors:  J L Rowen; J M Tate; N Nordoff; L Passarell; M R McGinnis
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

2.  Multiple gene genealogical analyses suggest divergence and recent clonal dispersal in the opportunistic human pathogen Candida guilliermondii.

Authors:  Lisa Lan; Jianping Xu
Journal:  Microbiology       Date:  2006-05       Impact factor: 2.777

3.  Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus.

Authors:  Julia Alcoba-Flórez; Sebastián Méndez-Alvarez; Josep Cano; Josep Guarro; Eduardo Pérez-Roth; María del Pilar Arévalo
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  A clinical isolate of Candida palmioleophila formerly identified as Torulopsis candida.

Authors:  T Sugita; K Kagaya; M Takashima; M Suzuki; Y Fukazawa; T Nakase
Journal:  Nihon Ishinkin Gakkai Zasshi       Date:  1999

5.  In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole.

Authors:  M A Pfaller; L Boyken; R J Hollis; S A Messer; S Tendolkar; D J Diekema
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

6.  Rapid identification of Candida species and other clinically important yeast species by flow cytometry.

Authors:  Brent T Page; Cletus P Kurtzman
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

7.  Rapid identification of Debaryomyces hansenii/Candida famata by polymerase chain reaction.

Authors:  A Nishikawa; T Sugita; T Shinoda
Journal:  Med Mycol       Date:  1999-04       Impact factor: 4.076

8.  Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III.

Authors:  Arianna Tavanti; Amanda D Davidson; Neil A R Gow; Martin C J Maiden; Frank C Odds
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

9.  Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata.

Authors:  Alexandra Correia; Paula Sampaio; Steve James; Célia Pais
Journal:  Int J Syst Evol Microbiol       Date:  2006-01       Impact factor: 2.747

10.  Two new species in the Pichia guilliermondii clade: Pichia caribbica sp. nov., the ascosporic state of Candida fermentati, and Candida carpophila comb. nov.

Authors:  Ann Vaughan-Martini; Cletus P Kurtzman; Sally Ann Meyer; Eric B O'Neill
Journal:  FEMS Yeast Res       Date:  2005-02       Impact factor: 2.796

View more
  26 in total

1.  Routine identification of medical fungi by the new Vitek MS matrix-assisted laser desorption ionization-time of flight system with a new time-effective strategy.

Authors:  Xavier Iriart; Rose-Anne Lavergne; Judith Fillaux; Alexis Valentin; Jean-François Magnaval; Antoine Berry; Sophie Cassaing
Journal:  J Clin Microbiol       Date:  2012-04-11       Impact factor: 5.948

2.  Assessment of accuracy of identification of pathogenic yeasts in microbiology laboratories in the United kingdom.

Authors:  Andrew M Borman; Adrien Szekely; Michael D Palmer; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

3.  Development of two molecular approaches for differentiation of clinically relevant yeast species closely related to Candida guilliermondii and Candida famata.

Authors:  Xiaobo Feng; Jingsong Wu; Bo Ling; Xianwei Yang; Wanqing Liao; Weihua Pan; Zhirong Yao
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

4.  Fluconazole Resistance in Isolates of Uncommon Pathogenic Yeast Species from the United Kingdom.

Authors:  Andrew M Borman; Julian Muller; Jo Walsh-Quantick; Adrien Szekely; Zoe Patterson; Michael D Palmer; Mark Fraser; Elizabeth M Johnson
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

5.  Yeast on-target lysis (YOTL), a procedure for making auxiliary mass spectrum data sets for clinical routine identification of yeasts.

Authors:  Mareike Bernhard; Michael Weig; Andreas E Zautner; Uwe Groß; Oliver Bader
Journal:  J Clin Microbiol       Date:  2014-09-17       Impact factor: 5.948

6.  Experimental therapy with azoles against Candida guilliermondii.

Authors:  Marta Sanchis; Francisco Javier Pastor; Javier Capilla; Deanna A Sutton; Annette W Fothergill; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

7.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometric identification and antifungal susceptibility analysis of Candida species isolated from patients with invasive yeast infections in five university hospitals.

Authors:  Zhimin Hu; Juling Zhang; Zhongju Chen; Zhengjiang Jin; Pei Leng; Junying Zhou; Xiaofang Xie
Journal:  Braz J Microbiol       Date:  2018-12-04       Impact factor: 2.476

8.  Characterization of a new clinical yeast species, Candida tunisiensis sp. nov., isolated from a strain collection from Tunisian hospitals.

Authors:  Jamel Eddouzi; Valérie Hofstetter; Marizeth Groenewald; Mohamed Manai; Dominique Sanglard
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

9.  Identification of medically relevant species of arthroconidial yeasts by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Anna Kolecka; Kantarawee Khayhan; Marizeth Groenewald; Bart Theelen; Michael Arabatzis; Aristea Velegraki; Markus Kostrzewa; Mihai Mares; Saad J Taj-Aldeen; Teun Boekhout
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

10.  Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs.

Authors:  Mariana Castanheira; Leah N Woosley; Daniel J Diekema; Ronald N Jones; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.